Skip to main content

Want a detailed portfolio tracker?

Nanobiotix (NBTX) P/E (2020 - 2026)

Nanobiotix (NBTX) P/E from Dec 11, 2020 to Jul 21, 2026. The TTM Nanobiotix (NBTX) P/E is -18.36. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nanobiotix (NBTX)

YearP/EChange
2026-18.36+70.50%
2025-10.77+594.33%
2024-1.55-48.51%
2023-3.01+129.24%
2022-1.31-35.70%
2021-2.04-41.74%
2020-3.51N/A

Comparison Nanobiotix (NBTX) P/E with competitors

Nanobiotix (NBTX) P/E is -18.36.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.41%
FGENFibroGen Inc0.24-101.31%
CHRSCoherus Biosciences Inc0.85-104.62%
FBIOFortress Biotech Inc0.95-105.17%
ORMPOramed Pharmaceuticals Inc1.50-108.19%
AGENAgenus Inc3.01-116.39%
INVAInnoviva Inc3.15-117.18%
VXRTVaxart Inc3.55-119.34%
CRMDCorMedix Inc3.63-119.76%
CVACCureVac N.V.4.45-124.22%
GLPGGalapagos NV4.86-126.47%
SRPTSarepta Therapeutics Inc4.88-126.59%
ABEOAbeona Therapeutics Inc5.39-129.35%
ABUSArbutus Biopharma Corp5.60-130.48%
ZVRAZevra Therapeutics Inc5.89-132.07%
SPROSpero Therapeutics Inc6.23-133.93%
CGENCompugen Ltd6.31-134.39%
RIGLRigel Pharmaceuticals6.87-137.43%
SLXNSilexion Therapeutics Corp7.30-139.74%
OMEROmeros Corporation9.26-150.43%
AUPHAurinia Pharmaceuticals Inc9.58-152.21%
PLXProtalix BioTherapeutics Inc10.89-159.32%
ACADAcadia Pharmaceuticals Inc11.73-163.88%
TBPHTheravance Biopharma Inc12.26-166.79%
ADMAAdma Biologics Inc12.42-167.64%
HRMYHarmony Biosciences Holdings Inc13.82-175.28%
SABSSAB Biotherapeutics Inc14.14-177.00%
INCYIncyte Corp15.82-186.18%
REGNRegeneron Pharmaceuticals Inc15.86-186.37%
PBYIPuma Biotechnology Inc17.32-194.32%
CPRXCatalyst Pharmaceuticals Inc17.44-194.99%
EXELExelixis Inc17.54-195.53%
TGTXTG Therapeutics Inc18.97-203.31%
MDXGMimedx Group Inc20.55-211.95%
XOMAXOMA Royalty Corp22.87-224.60%
ARGXArgen X SE24.30-232.35%
CTMXCytomX Therapeutics Inc24.82-235.20%
XOMAOXOMA Royalty Corp25.34-238.06%
HALOHalozyme Therapeutics Inc25.62-239.57%
XOMAPXOMA Royalty Corp25.67-239.83%
VRTXVertex Pharmaceuticals Inc27.99-252.49%
RPRXRoyalty Pharma plc - Class A28.69-256.26%
SLNOSoleno Therapeutics Inc29.02-258.05%
ASNDAscendis Pharma A/S30.09-263.88%
LGNDLigand Pharmaceuticals Inc - Class B37.91-306.51%
APLSApellis Pharmaceuticals Inc39.02-312.55%
BMRNBiomarin Pharmaceutical Inc42.21-329.93%
KRYSKrystal Biotech Inc45.34-346.99%
ONCBeiGene Ltd69.54-478.79%
PHARPharming Group N.V.75.03-508.67%
TECHBio-Techne Corp101.96-655.38%
VCELVericel Corp109.92-698.75%
ALNYAlnylam Pharmaceuticals Inc117.96-742.57%
GMABGenmab140.29-864.18%
TLXTelix Pharmaceuticals Ltd162.15-983.26%
CORTCorcept Therapeutics Inc212.86-1259.46%